Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

849484958496849784988499850085018502850385048505850685078508850985108511851285138514851585168517851885198520852185228523852485258526852785288529853085318532853385348535853685378538853985408541854285438544854585462011 Nov 2;103(21):1639. Kim, George P [added]. PubMed PMID: 21597022; PubMed Central PMCID:PMC3110173.Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic,predictive, and therapeutic implications. Clin Cancer Res. 2012 Mar 15;18(6):1506-12. doi: 10.1158/1078-0432.CCR-11-1469. Epub 2012 Feb 2. PubMed PMID: 22302899; PubMed Central PMCID: PMC3306518.Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection forsphincter-preserving surgery. Cancer 1995;76:388-392.Skibba JL, Quebbeman EJ.Tumoricidal effects and patient survival after hyperthermic liver perfusion.Arch Surg1986;121:1266-1271.Slater A, North M, Hart M, Ferrett C. Gas insufflation of minimal preparation CT of the colon reduces falsepositives.Br J Radiol. 2012 Apr;85(1012):346-50. doi: 10.1259/bjr/20678489. Epub 2011 Jan 11.Sloothaak DA, Buskens CJ, Bemelman WA, Tanis PJ. Treatment of chronic presacral sinus after low anteriorresection. Colorectal Dis. 2012 Dec 5. doi: 10.1111/codi.12094. [Epub ahead of printSloothaak DA, Geijsen DE, van Leersum NJ, Punt CJ, Buskens CJ, Bemelman WA, Tanis PJ; Dutch SurgicalColorectal Audit. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. BrJ Surg. 2013 Jun;100(7):933-9. doi: 10.1002/bjs.9112. Epub 2013 Mar 27.Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, et al. Phase III trial of fluorouracilbasedchemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J ClinOncol 2006; 24: 3542-7.Smidt ML, Wegdam JA, Bremers AJ, Bleichrodt RP. Missing evidence for the adequacy of a 1-cm distal margin inresected rectal cancer. Ann Surg Oncol 2003;10:823-24.Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressureand type of vascular control in blood loss during major liver resections.Am J Surg 2004;187:398-402.Snoeren N, Voest EE, Bergman AM, Dalesio O, Verheul HM, Tollenaar RA, van der Sijp JR, et al. A randomizedtwo arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigatebevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.BMC Cancer. 2010 Oct 11;10:545. doi: 10.1186/1471-2407-10-545.Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). TNM Prognostic FactorsProject, International Union Against Cancer, Washington, DC, USA.Sobin LH, Wittekind CH (Eds). TNM Classification of Malignant Tumours, 6th Edition. International Union AgainstCancer, Washington, DC, USA, 2002.Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of livermetastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases.Eur JUltrasound 2001;13:149-158.Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases fromcolorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-166.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 194